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This dissertation is presented in a manuscript format following the College of Health Sciences 
guidelines for thesis/dissertation submissions at the University of KwaZulu-Natal. The study's 
main findings are presented as two manuscripts in chapters 2 B and 3 of this dissertation. Chapter 
2 A, presented as a manuscript, was developed to guide the conduct of chapter 2 B. Chapter 2 A, 
2 B, and 3 have respectively been submitted to Systematic Reviews (SYSR), Value in Health 
Regional Issues (VIHRI), and European Journal of Cancer (EJC). The references used in the 
manuscripts were cited according to the instructions/guidelines for authors as required by the 
journals. A complete reference list is presented at the end of each manuscript chapter, following 
the journal's reference style.   
The dissertation consists of four (4) chapters as follows: 
Chapter 1: This chapter presents the introduction/background, problem statement, justification, 
aim, specific objectives, and the theoretical and conceptual framework of the study. The chapter 
further explains the study’s general methodology, data analysis, management, ethical 
considerations, and finally includes chapter conclusions. 
Chapter 2 A: The first manuscript for publication presents an original review protocol entitled 
‘‘The Awareness of Women about Prostate Cancer: A Mixed-Methods Systematic Review 
Protocol,’’ which was submitted according to SYSR authors’ guidelines. 
Chapter 2 B: The second manuscript for publication presents an original review entitled ‘‘Prostate 
Cancer Awareness among Women: A Mixed-methods Systematic Review,’’ which was submitted 
according to VIHRI authors’ guidelines. 
Chapter 3: The final manuscript for publication presents an original study entitled ‘‘An Akan 
Translation, Validation and Reliability of a Questionnaire for assessing the Awareness of Ghanaian 
women about Prostate Cancer,’’ which was submitted according to EJC authors’ guidelines. 
Chapter 4: This chapter concludes the study. The chapter elaborates on the key findings, study 
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Background and Objectives: The incidence of prostate cancer in developing countries is less than 
30%, yet it has the disease's highest mortality. To address the mortality, strategies to increase 
awareness of the disease have been proposed, including the recommendation for women's active 
involvement. This is because women act as family health advocates, advisors, managers, and 
promoters. Therefore, it is essential to gather evidence on women's awareness of prostate cancer. 
Also, in Ghana, there is a lack of evidence about women's awareness of prostate cancer. However, 
there are about 50 indigenous Ghanaian languages, with Akan been the most spoken language. 
Providing a valid and reliable Akan version of a modified tool for assessing Ghanaian women's 
awareness of prostate cancer is vital. The study aim was (1) to conduct a mixed-methods systematic 
review on the awareness of women regarding prostate cancer, and (2) to translate, validate, and 
conduct a reliability assessment of a questionnaire for studying the knowledge, awareness, and 
perception of prostate cancer in Ghanaian market women. 
Methods: The Joanna Briggs Institute manual was employed in the development of a mixed-
methods systematic review protocol. The protocol was then used to conduct a systematic review 
of the awareness of women on prostate cancer. MEDLINE (EBSCOhost), CINAHL (EBSCOhost), 
PsycINFO (EBSCOhost), Web of Science, and EMBASE (Ovid) were searched based on the 
inclusion criteria for studies conducted between 1999 to 2019. Also, questionnaires on prostate 
cancer awareness were adopted from other studies, modified, and translated to Akan using the 
forward and backward translation protocols. The Akan questionnaire was certified, validated, and 
a reliability assessment was performed by measuring average scores, content validity index, and 
Cronbach’s alpha, respectively. Study participants for the validation and reliability study were 
recruited using a simple random sampling technique. 
Results: A total of 2201 articles were identified from the search, of which seven were included in 
the review. The selected studies' results indicated moderate knowledge on signs and symptoms; 
and causes and risk factors of prostate cancer. An inadequate level of knowledge about prostate 
cancer screening tools was recorded among women. An Akan questionnaire was adequately 
developed and certified. The average scores for all parameters employed in the face validation 
were greater than 4. The content validity index was within the range of 0.90 - 0.99 whilst 
Cronbach’s alpha within the range of 0.7808 - 0.9209. 
xxi 
 
Conclusion: The selected studies indicated moderate awareness about prostate cancer among 
women. The selected studies for the review were few; hence this hinders the generalizability and 
transferability of the results.  More studies should be conducted on prostate cancer awareness 
among women to promote their role in disease prevention. The Akan questionnaire for assessing 







Prostate cancer (PCa) emerges when cells found in the prostate gland, present in men, set off on a 
path of unregulated growth (Saleh, Fooladi, Petro-Nustas, Dweik, & Abuadas, 2015). The 
malignant disease is usually present without warning signs at the initial stages, often resulting in 
late diagnosis (Cancer.Net., 2019; Saleh et al., 2015). The disease diagnosis in terminal stages is 
the major setback in management and hence accounts for increased mortality in Africa (Chu et al., 
2011; Magoha, 2007). The high burden of cancers in Ghana has led to the conception of a national 
document entitled National Strategy for Cancer Control (Ministry of Health [MoH], 2011) to 
control various cancers in the country. 
1.1.1 EPIDEMIOLOGY  
The Global Cancer Incidence, Mortality and Prevalence(GLOBOCAN, 2018) epidemiological 
report documented 18.1 million new cases of various cancers of which prostate cancer accounted 
for 1.3 million (7.1%) (Bray et al., 2018). Regarding the status in Ghana, 2,132 prostate cancer 
cases, representing 9.9% of all cancer cases, were diagnosed (GLOBOCAN, 2018).  
1.1.2 DISEASE BURDEN  
Although all men are at risk for developing prostate cancer, men of African descent account for 
the highest incidence (Bennett & Badger, 2005). The World Health Organization (WHO) estimates 
an increased burden of various malignancies in sub-Saharan Africa (SSA) (Kingham et al., 2013). 
It is imperative to note that the late diagnosis of prostate cancer in sub-Saharan Africa has been 
speculated to be about 80% (Kingham et al., 2013). The late diagnosis of prostate cancer in Africa 
accounts for the increased mortality rate (Chu et al., 2011; Magoha, 2007). This is evident as 64% 
of patients were found to have reported for care at advanced stages and hence, died within two 
years (Magoha, 2007).  
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Chu et al. (2011) further stressed the situation of PCa in Ghana where  75% of newly diagnosed 
prostate cancer patients were already at advanced stages (Chu et al., 2011). Therefore, the 
significantly unacceptable burden of prostate cancer, as established by mortality records, is mainly 
due to late diagnosis. 
1.1.3 CLINICAL MANIFESTATIONS 
According to Saleh et al. (2015) prostate cancer is usually asymptomatic (Saleh et al., 2015). Signs 
and symptoms, which usually present at terminal stages, include reduced sexual performance, 
fatigue, pain, and urinary discomfort (Bennett & Badger, 2005). Urinary symptomatology includes 
painful urination, interrupted urine flow, hematuria, urinary urgency, and urinary frequency 
(Cancer.Net., 2019; Saleh et al., 2015). 
1.1.4 CAUSES AND RISK FACTORS 
All men are at risk of developing prostate cancer (Gupta & Guin, 2010; Hayat, Howlader, 
Reichman, & Edwards, 2007; Surveillance, Epidemiology, and End Results Program [SEER], 
2019).  
The disease has been linked to a man’s racial background, and a genetic link to Africa, following 
careful statistical analysis (SEER, 2019). Further study findings show that several factors 
predispose a man to develop PCa. According to the  National Cancer Institute, a family history of 
prostate cancer - specifically, the presence of a first-degree relative - significantly increases a 
man’s risk (PDQ Screening and Prevention Editorial Board, 2020). Also, exposure to carcinogenic 
chemicals and drugs; the consumption of foods with carcinogenic contents; and medical conditions 
such as prostatitis; are causes of PCa (PDQ Screening and Prevention Editorial Board, 2020). 
1.1.5 SCREENING RECOMMENDATIONS 
The benefits of early diagnosis through screening have been highlighted by Schröder et al. (2009) 
who revealed that a 20% reduction in mortality rate could be achieved through early screening and 
diagnosis (Schröder et al., 2009). Prostate-specific antigen (PSA) and the digital rectal examination 
3 
 
(DRE) are amongst the most widely utilized techniques for PCa screening (Andriole et al., 2009; 
Qaseem, Barry, Denberg, Owens, & Shekelle, 2013; Schröder et al., 2009).  
The concomitant use of the PSA and the DRE has been useful in PCa detection (Schröder et al., 
2009). The addition of ultrasonographic investigations to PSA-DRE combination has also proven 
to be extremely beneficial in improving the quality of PCa detection (Schröder et al., 2009). Results 
obtained from the routine screening with PSA alone, DRE alone, PSA-DRE combination, or PSA-
DRE-Ultrasonography combination have informed the need for pathological investigations in an 
attempt to arrive at a certified diagnosis which often informs the treatment approach to select 
(Schröder et al., 2009). 
Also, there is the potential of magnetic resonance imaging (MRI) for the diagnosis and 
characterization of PCa (Dickinson et al., 2011). It is recommended that men screen for the disease 
as they age (Qaseem et al., 2013).  
1.1.6 MANAGEMENT APPROACHES 
The approaches to the management of PCa are guided by government policies on health and 
regional treatment recommendations (Schröder et al., 2009). According to the European 
Association of Urology (EAU), modalities for the management of PCa include; delayed 
management; surgical management; radiotherapy, and pharmacotherapy (European Association of 
Urology [EAU], 2020). In addition to the conventional treatment options, investigations are still 
ongoing to evaluate the efficacy of cryotherapy, high-intensity focused ultrasound, and focal 
therapy (EAU, 2020). 
1.2 PROBLEM STATEMENT 
The 2018 incidence of cancers in Ghana had been determined to be 22,823 and prostate cancer 
accounted for 2,132 (9.9%) (GLOBOCAN, 2018). A previous study by Chu et al. (2011) 
highlighted the troublesome nature of the late diagnosis of PCa in Ghana (Chu et al., 2011). Hence, 
PCa is a significant public health threat to the Ghanaian community. There are no national policies 
dedicated to the early detection and control of prostate cancer in Ghana. The cancer document 
published in 2011 by the Ministry of Health, Ghana, was to be employed in the control of various 
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cancers from 2012 to 2016 (MoH, 2011). Therefore, the unavailability of an updated national 
cancer control document and the total absence of a prostate cancer control document are national 
concerns.  
Over the years, much attention has been placed on other types of cancers, mainly breast cancer, 
ignoring the prostate (Fitzpatrick, Kirby, Brough, & Saggerson, 2009). An assessment of cancer 
publications revealed that breast cancer had 40% more articles than prostate cancer (Fitzpatrick et 
al., 2009). Furthermore, the findings from the international survey by Fitzpatrick et al. (2009) 
reported a lower media publicity of prostate cancer as compared to other cancers (Fitzpatrick et 
al., 2009). On the part of clinical research to investigate newer and more advanced ways of 
screening, diagnosing, and managing cancers, prostate cancer has also suffered a great degree of 
neglect (Fitzpatrick et al., 2009). Although these figures might have changed, in an attempt to 
reduce mortality it is imperative to throw more light on prostate cancer with attention on exploiting 
ways of increasing early detection as recommended by the WHO (World Health Organization 
[WHO], 2019). Therefore, the research and publicity deficits plighting prostate cancer require 
closure. 
In exploiting a cost-effective approach to enhance the early detection of prostate cancer with the 
sole aim of reducing mortality, this study seeks to develop an Akan questionnaire to contribute to 
the identification of gaps in the knowledge, awareness, and perception of women towards the early 
detection of prostate cancer. The study, upon conclusion, will propose recommendations to identify 
and address knowledge gaps. 
1.3 JUSTIFICATION 
The development of a tool to investigate women’s awareness of prostate cancer would contribute 
to the early detection of the disease. It has been proven that prostate cancer diagnosis at advanced 
stages is associated with increased mortality and poor quality of life in survivors. The publicity of 
prostate cancer is significantly low in the global context where studies involving women were low 




In Ghana, there has been a call for innovative ways to promote the early detection of prostate 
cancer (Chu et al., 2011). This call has been a result of the increased mortality associated with late 
diagnosis. The Akan language is spoken by the majority of Ghanaians, and the Ghanaian 
population is composed of over 50% of women. Hence, the development of an Akan tool aimed at 
positioning women at the center of the strategy to promote the early detection of prostate cancer 
by exploiting their health promotion and protection qualities is essential (Karim, Lindberg, 
Wamala, & Emmelin, 2018; Somani, 2017). 
According to a study by Mensah et al. (2020), members of the Community Pharmacy Practitioners 
Association of the Pharmaceutical Society of Ghana have a positive attitude towards the promotion 
of cancer health (Mensah, Oosthuizen, & Bangalee, 2020). Pharmacists have been useful in 
improving the quality of life of cancer patients through counselling (Periasamy et al., 2020). 
Hence, practitioners of pharmacy could exploit their counselling skills to encourage women to 
push their male significant others to screen for prostate cancer. Also, community pharmacists could 
make use of a prostate cancer knowledge assessment tool to assess the knowledge of women who 
visit their facilities and further educate these women to close knowledge gaps.   
A literature search before the conception and initiation of this study did not discover any studies 
that developed a Ghanaian tool to investigate women’s awareness of prostate cancer. Hence, the 
uniqueness of this study. 
1.4 AIM 
The core aim of this research was to develop a tool to be used specifically in Ghana to study the 
knowledge, awareness, and perception of women about prostate cancer. 
1.5 SPECIFIC OBJECTIVES 
1) To conduct a mixed-methods systematic review on the awareness of women about prostate 
cancer. 
2) To translate, validate, and conduct a reliability assessment of a questionnaire for studying the 
knowledge, awareness, and perception of prostate cancer in Ghanaian market women. 
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1.6 THEORETICAL AND CONCEPTUAL FRAMEWORK 
The theory underpinning this study is the attachment theory (Figure 1) also referred to as the 
relationship theory (Pietromonaco, Uchino, & Dunkel Schetter, 2013). The theory describes the 
effect of closed bonds in nature as observed in wives-husbands relationships and parents-children 
relationships (Bowlby, 1973; Collins & Feeney, 2010; Mikulincer & Shaver, 2007). This theory, 
exhibited in the adult population as illustrated in this study, has presented the scientific community 
with a powerful explanation of terms in addition to having a clear-cut significant impact on health 
outcomes (Mikulincer & Shaver, 2007; Pietromonaco et al., 2013). In wellness domains such as 
obstetrics (Buka, Brennan, Rich-Edwards, Raudenbush, & Earls, 2003; Dunkel Schetter, 2011); 
psychology (Dunkel Schetter, 2011; Feeney, Peterson, Gallois, & Terry, 2000); weight 
management (Dailey, Romo, & Thompson, 2011); diabetes management (Stephens, Rook, Franks, 
Khan, & Iida, 2010); HIV control (Burton, Darbes, & Operario, 2010); smoking cessation and 
cardiac health (Lewis & Butterfield, 2007; Vilchinsky et al., 2011), cancer management (Belcher 
et al., 2011; Manne et al., 2004); chronic pain management (Cremeans-Smith et al., 2003; 
Meredith, Ownsworth, & Strong, 2008); and geriatric care provision (Karantzas, Evans, & Foddy, 




Figure 1: Theoretical framework illustrating attachment theory (Pietromonaco et al., 2013). 
The study is also rooted in the concept of social networks and social support (Figure 2) (Glanz, 
Rimer, & Viswanath, 2008) as there is enough evidence establishing a link between the theory and 
concept guiding this study (Glanz et al., 2008; Pietromonaco et al., 2013). Historically, the social 
network was researched and presented as a theory until Barnes presented it as a concept in the 
1950s (Barnes, 1954). Social support could be emotional, instrumental, informational, or appraisal 
(Glanz et al., 2008). This study, amongst the aspects of social support, will mainly utilize 
informational support by testing the knowledge and awareness of women on prostate cancer with 
a focus on making recommendations aimed at equipping women to transmit information about the 
disease to men. In discussing women’s perception about prostate cancer, the study will focus on 
utilizing emotional and instrumental support as men will benefit from recommendations 
addressing negative perceptions that may be discovered in women. With respect to appraisal 
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support, the study will benefit women as their knowledge, awareness and perception on the disease 
will be assessed. Hence, the study seeks to satisfy the four dimensions of social support. 
 
 
Figure 2: Conceptual framework illustrating Social Networks and Social Support (Glanz et al., 
2008). 
1.7 GENERAL METHODOLOGY 
1.7.1 STUDY DESIGN 
A cross-sectional, quantitative, descriptive study design was employed in this research project. 
1.7.2 STUDY SETTING 
The research was conducted on the Kumasi Central Market (KCM). The Kejetia Market (popularly 
known as KCM) is located in the Ashanti Region of Ghana (Kumasi as the capital town). The 
market was designed to hold about 300,000 individuals who could be evacuated, in times of 
emergencies, within an estimated 12-minute duration. The facilities in the market include; shops 




Figure 3: Map of Ghana illustrating the 16 administrative regions. 
Source: https://commons.wikimedia.org/wiki/File:NEW_GHANA_REGIONS.jpg  
 
 










Figure 6: Internal view of the Kejetia Market illustrating the layout of shops. 
Source: http://archpose.com/the-new-kejetia-market-project-update/   
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1.7.3 STUDY SUBJECTS 
The category of individuals at KCM recruited for this study was females who offered items for 
sale at the market. According to the administrative manager, the estimated number of potential 
study subjects, from which the appropriate sample size was calculated, was 25,000. 
1.7.3.1 INCLUSION CRITERIA 
 Female sellers at the Kumasi Central Market. This was due to their availability for the test and 
retest stages of the study as compared to female buyers. 
 Female sellers who consented to the study. 
1.7.3.2 EXCLUSION CRITERIA 
 Supporting female staff, including female head porters, of recruited participants. This category 
of market women moves from one point to another. Hence, their inclusion would have posed 
significant challenges in the retesting of the questionnaire. This is because it would be difficult 
to track such participants. 
 Female sellers who did not consent to the study. 
 Women who were on the market as relatives and friends of study subjects. 
 Women who were below 18 years at the time of sampling. 
1.7.4 SAMPLE SIZE AND SAMPLING TECHNIQUE 
The developed prostate cancer awareness tool was subjected to a reliability assessment by testing 
and retesting the tool in a sample of women on the Kumasi Central Market. The reliability study 
was to determine the ability of the tool to effectively measure the study domains over some time. 
In determining the sample size for the reliability study, a confidence level (c) of 95% was set. 
Other parameters included a precision level (e, sampling error) of +/-5% and a degree of variability 
(p) of 50%. The sample size obtained using a published table (Figure 7) by Israel (1992), 
considering the estimated 25,000 market women, was 394 (Israel, 1992). Therefore, for a 
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conventional study, approximately 400 women are appropriate. However, 25% (i.e. 100 women) 
of the required sample size was employed in the reliability assessment of the questionnaire to 
obtain an intra-class correlation coefficient (ICC) of not less than 0.75±0.1 at a 95% confidence 
interval (Rogers et al., 2016). This is supported by the evidence that some studies recruited a lesser 
sample size (Sowtali, Yusoff, Harith, & Mohamed, 2016) and relatively higher sample sizes 
(Nahad et al., 2014; Rogers et al., 2016). The market women were sampled according to the simple 
random sampling technique.  
 
Figure 7: Sample size for selected population sizes (Israel, 1992). 
1.7.5 DATA COLLECTION TOOL AND METHOD 
The data extraction tool was originally developed in the English language and later translated into 
the Akan language. The tool was made of six (6) sections comprising forty-five (45) items. Data 
collection for the reliability assessment commenced on June 8, 2020, and ended on June 19, 2020. 
The certified Akan version of the questionnaire was read to participants after obtaining informed 
consent and answers, provided by participants, were entered with the Census and Survey Entry 
(CSEntry) mobile application for easy data handling. 
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1.8 DATA COLLECTION PROCEDURE 
An English version of the prostate cancer awareness tool was adopted and modified. The English 
tool then went through a translation procedure into the Akan language by three English and three 
Akan translators. The translation method employed was the forward (translation from English to 
Akan) and backward (translation from Akan to English) translation techniques. The final English 
document was compared to the original English document for textual equivalence. The Akan tool 
was approved, certified, and subjected to a validity and reliability assessment.  
The face and content validity analysis was performed utilizing six (6) non-experts (market women) 
and six (6) experts (healthcare professionals), respectively. These individuals voluntarily scored 
the variables of the tool according to set criteria. 
The reliability assessment of the tool, which employed the test-retest method, recruited 100 market 
women at the Kumasi Central Market. The women were randomly recruited and guided to respond 
to the tool after informed consent was obtained. The interval between the test and retest periods 
was seven days, and the process was completed in 14 days. During the random sampling stage, the 
market ground floor was divided into four (4) sections. Each section was sub-sectioned into five 
(5). Four (4) women were selected per sub-section to make 100 women for the reliability study. 
The selected women were revisited after a week to complete the data collection procedure.  
1.9 DATA ANALYSIS AND MANAGEMENT 
CSEntry mobile application was used for the data entry, and the STATA software was used for the 
statistical analysis. A summary of the descriptive data was presented as tables. The average validity 
score was calculated to assess the questionnaire face validity, and the Content Validity Index 
(CVI). Cronbach’s alpha was employed for the determination of internal reliability.  
To secure the participants' interest, the highest standard of confidentiality, gathered data has been 





1.10 ETHICAL CONSIDERATION 
The study was granted two ethics approvals. The primary, local ethics, approval was obtained from 
the Committee on Human Research, Publications and Ethics (CHRPE) of the Kwame Nkrumah 
University of Science and Technology (KNUST), Ghana. CHRPE reference number: 
CHRPE/AP/127/20 (Appendix 3). The secondary and final ethics approval was obtained from the 
Biomedical Research Ethics Committee (BREC) of the University of KwaZulu-Natal (UKZN), 
South Africa. BREC reference number: BREC/00001292/2020 (Appendix 1). These ethical 
approvals enabled the conduct of the study indicated in chapter 3. The Kumasi Metropolitan 
Assembly, through the Kejetia administrative manager, granted permission for the use of the 
market as the research site. 
Informed consent was obtained from respondents and witnessed. Each participant was given a non-
monetary gift after the successful completion of the questionnaire as an appreciation. 
1.11 CONCLUSIONS 
This chapter highlighted the burden of prostate cancer and the need for increased awareness in an 
attempt to promote the early detection of the disease. The chapter also emphasized the need to 
explore cost-effect ways to address the knowledge deficits of prostate cancer in women. The 
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In chapter 1, the study's introduction, the general methodology employed, and the study's ethical 
consideration was presented. The literature reviewed in this study is described in chapter two in 
the form of manuscripts. This is presented in two sub-chapters (Chapter 2 A and 2 B). Chapter 2 
A presents the development of a mixed-methods systematic review protocol that was used to guide 
the mapping up of current evidence of women on prostate cancer. The manuscript was prepared 

























CHAPTER 2 A 
SUBMITTED MANUSCRIPT 
The Awareness of Women about Prostate Cancer: A Mixed-Methods Systematic Review 
Protocol 
Abstract 
Background: Prostate cancer accounts for about 10% of cancers affecting and claiming the lives 
of men. Studies have reported that women are better than men in recognition of the early 
manifestations of various cancers. Furthermore, women have been recognized to show a profound 
interest in their partners' health and hence, make observations that men don't know. Several studies 
have reported on the knowledge gaps of prostate cancer among patients and the general population. 
It is vital to comprehensively review the available evidence and identify research gaps in our 
current understanding of knowledge of women on prostate cancer. 
Methods: A search of bibliographic databases, MEDLINE (EBSCOhost), CINAHL 
(EBSCOhost), PsycINFO (EBSCOhost), Web of Science, and EMBASE (Ovid) will be 
undertaken from January 1999 to December 2019. The search will be limited to studies published 
in the English language. Duplication of studies will be removed using the EndNote citation 
manager. After deduplication, citations will be screened independently by two authors according 
to prespecified criteria. Data extraction and quality assessment of the selected studies will be done 
independently by two authors. Meta-analytic methods will be used where appropriate. The 
convergent segregated method of synthesis will be adopted in this review.  
Ethics and dissemination: Primary data collection will not be involved in this study, hence formal 
ethical clearance will not be needed. The results of the study will be presented through a peer-
reviewed journal and conference presentation. 
Patient and public involvement: Patients or the public will not be engaged in the conduct of this 
study. 





Prostate cancer is a common neoplasm in men, and its occurrence keeps rising in many countries 
[1]. It is number three on the global list of the most common cancers that claim the lives of men 
[2,3]. The incidence rate, mortality rate, and the rate of diagnosis of prostate cancer have been 
documented to be 0.5 million per year, a man per 2 minutes, and almost 2000 men per day, 
respectively [2,4]. In addition to the global burden of the disease, prostate cancer accounts for 
about 10% of cancers affecting men [2]. Thus, prostate cancer is of significant public health 
interest. 
A study conducted by Quinn and Babb (2002) indicated a reduction in prostate cancer mortality 
from early detection [2]. Other studies have also indicated the importance of the early detection of 
the disease to reduce mortality [5,6]. In North America, the establishment of Rapid Access Prostate 
Clinic (RAPC) and more extensive advocacy of prostate cancer to the general population, with 
global campaigns such as Movember (ie.movember.com), has decreased the mortality of the 
disease [7]. Hence, measures to improve the early detection of the disease among the general 
population can have a significant impact on the disease. 
There are scientific shreds of evidence to support the claim that women can be trusted with family 
health [5,8]. Blanchard et al. (2005) reported that women are better than men in the following 
aspects of cancers; the recognition of the early manifestations of various cancers, the timely 
perception of the barriers to seeking help, and the timely report of the identified barriers [5]. 
Women have reported on breast cancer and cervical cancer, where education has equipped them 
to be in control of their health [9]. Also, women have been recognized as individuals who show a 
profound interest in their partners’ health. Hence, they can make observations that men themselves 
do not observe about their health [9]. Much evidence exists on the critical role of women in 
decision-making in the treatment of their spouse or partner diagnosed with prostate cancer [10,11]. 
Similar studies have also explored their potential role in screening the disease. Scant data exist on 
the knowledge of women about prostate cancer. Therefore, it is essential to map up evidence to 




A survey conducted by Fitzpatrick et al. (2009) concluded that the public and patients are aware 
of prostate cancer but with certain knowledge gaps. It concluded that measures have to be taken to 
address the identified knowledge gaps [4]. It is essential to gather information on the current 
knowledge of prostate cancer in the general population. However, this review focuses on women, 
as public health care largely depends on women’s contributions, particularly in health education 
[12]. The study aims to map up existing evidence about the awareness of women about prostate 
cancer. 
Review question 
Do women have adequate knowledge about prostate cancer?  
Objectives of the study 
1. To assess the knowledge-base of women on the signs and symptoms of prostate cancer. 
2. To determine the awareness of women on the risk factors and causes of prostate cancer. 
3. To ascertain the knowledge of women on the availability of screening guides for the early 
detection of prostate cancer. 
Methods and Analysis 
The mixed-methods approach will be employed in this systematic review. The Joanna Briggs 
Institute (JBI) reviewer’s manual, with a focus on mixed methods systematic reviews, will be 
utilized [13]. The mixed-methods approach to research, which is among the first three widely used 
research approaches, has gained popularity due to its ability to analyze data obtained from 
quantitative, qualitative, and primary mixed-methods research papers [14,15]. The mixed-methods 
approach is also appropriate to permit data triangulation to enhance the study validity [16]. In 
addition to this benefit, the use of mixed-methods has proven to be useful in comparing and 
contrasting quantitative and qualitative research findings. This results in either the quantitative 
findings supporting the qualitative findings or vice versa [16]. To ensure that findings that have 
the highest recognizable strength are obtained at the end of the systematic review, the role of the 
mixed-methods approach in this review is important [13]. This critical appraisal and synthesis is 
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registered with Open Science Framework and can be accessed through  
https://doi.org/10.17605/OSF.IO/EYHF2 and will commence in July 2020. 
 
Eligibility criteria 
Population of interest 
The population of interest is women who are 18 years of age or above. The review will include 
research papers that involve women who are 18 years of age or above as part of the study 
population. In addition to the description of the interest population (women who are 18 years and 
above), the features of women in included studies will not be restricted to cultural/sub-cultural 
backgrounds and geographical locations. 
Interest phenomena 
The phenomenon of interest for this review is the awareness of women on prostate cancer. 
Therefore, this review will involve studies that evaluated the knowledge of women aged 18 years 
and above on prostate cancer.  
Context of interest 
The context of interest will include but not limited to all studies conducted in women of all 
cultural/sub-cultural backgrounds and geographical locations. 
Outcome 
The review will consider research papers that have the knowledge of women on the signs and 
symptoms, causes and risk factors, and screening recommendations of prostate cancer as the 
outcome measures. 
Types of studies to be included 
This critical appraisal and synthesis would involve primary research papers that are qualitative, 
quantitative, and mixed-methods in nature. Focused group discussions (FGD), observation of 
study subjects (follow-up studies), in-depth interviews, and other forms of interviews will 
constitute the qualitative studies to be included in this systematic review without ignoring other 
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studies that meet the criteria of qualitative studies. Quantitative studies will constitute descriptive 
studies, descriptive cross-sectional studies, and other studies that meet the requirements of 
quantitative studies. Studies that combined qualitative and quantitative designs will constitute the 
mixed-methods arm of this study on a condition that the qualitative and quantitative data can be 
explicitly extracted. This review will also include studies that have been published in the English 
language. To be able to map up current evidence, studies dating January 1999 - December 2019 
will be included in this review. 
Exclusion criteria 
The following will be grounds for excluding papers for this review: 
 Studies that were published before January 1999 or after December 2019. 
 Studies that were not published in the English language. 
 Studies that include women below the age of 18 years. 
 Studies in which the age of included women cannot be established. 
 Studies that did not indicate the number of included women. 
 Studies that exclusively included male without any female gender (18 years and above). 
 Studies conducted amongst women who were previously given education on prostate 
cancer. 
 Studies involving lesbian, gay, bisexual, transsexual/transgender, and queer/questioning 
(LGBTQ) participants. 
 Studies that included healthcare professionals. 
 Studies that included healthcare and college/university students. 
 Studies that do not include the outcome of interest. 
 Book chapters. 
 Reviews and overviews. 
 Abstracts and conference papers. 
 Dissertations and thesis. 
 Commentaries and letters to editors.  




Information sources and search strategy 
A comprehensive search strategy will be developed by the primary author (EW) to identify various 
publications related to the study. The following databases will be searched; MEDLINE 
(EBSCOhost), CINAHL (EBSCOhost), PsycINFO (EBSCOhost), Web of Science, and EMBASE 
(Ovid). The searched period will be from January 1999 to December 2019. 
A triple stage approach to searching published literature will be adopted in developing the 
preliminary search strategy [13]. Firstly, MEDLINE (EBSCOhost) will be searched for articles 
relevant to this review. Subject terms (identified from the title and abstract of the relevant papers) 
and free text terms (identified from the description of the relevant papers) will be employed in the 
development of the preliminary search strategy. The preliminary search strategy, using MEDLINE 
(EBSCOhost), has been affixed (Appendix 1). Secondly, the preliminary search strategy will be 
adopted in the search for relevant studies from CINAHL (EBSCOhost), PsycINFO (EBSCOhost), 
Web of Science, and EMBASE (Ovid), respectively. The citation list of the selected studies for 
the review will be scanned for additional studies. Search findings, which will be in the English 
language, will be compiled independently by two authors (EW and KBM). 
The total search findings of EW and KBM will be compiled and duplicate papers, removed with 
the help of the EndNote X8 software, to generate a final list of search findings for the review.  
Screening and selection of studies 
The final list of search findings will be independently screened by two reviewers (EW and KBM). 
The titles and abstracts of the selected studies will initially be screened for inclusion and exclusion 
in the review. Studies that are selected after the screening of the titles and abstract will undergo 
full-text reading by the same independent reviewers. The selection for data extraction will be done 
by a careful comparison of papers that successfully passed the screening stage to the established 
inclusion and exclusion criteria. Search findings that present disagreements between the 
independent reviewers, during the screening and selection stages, will be resolved through 
discussions with the third reviewer (ABBM). Cohen’s kappa will be used to measure inter-rater 
agreement between the two independent reviewers in each screening phase. Reference 




The JBI quantitative and qualitative data extraction tools, appendix 2 [17-19] will be adopted to 
extract data from search findings. The convergent segregated approach to data synthesis and data 
integration recommends using separate data extraction tools for this review [13]. Data that will be 
extracted from the included studies will not be restricted to the study title, principal investigator 
(lead author), year of publication, the country in which the study was conducted, the study sample 
size, the study design, ethnic background of study participants, key discoveries of the study, the 
limitations of the study and conclusions made by authors. Two reviewers (EW and KBM) will 
independently extract both quantitative and qualitative data. The outcome of the individual data 
extracted by these two authors will be merged to generate a final pool of data for the review. 
Disagreements that may arise when building the final pool of data will be resolved through 
discussions with ABBM. 
Assessment of methodological quality 
The quality assessment of the review will adopt and adapt a quality appraisal tool employed in a 
review conducted by Mensah et al., (2018) appendix 3 [20]. The tool has 5 general quality 
assessment criteria and 3 specific quality assessment criteria to be scored over 100%. The design 
of the tool will permit the comparison of scores obtained by individual literature to the scoring 
benchmark of weak (0 – 33.9%), moderate (34% – 66.9%), and strong (67% – 100%) (20). This 
quality appraisal stage will be done independently by two authors (EW and KBM). It is 
recommended that a minimum of two reviewers be involved in the appraisal of the quality of 
studies to be considered for data extraction and subsequent synthesis [19,21]. Hence, the need for 
EW and KBM to independently conduct a quality assessment of search findings that passed the 
screening and selection stage of the review. The results obtained from the quality assessment stage 
will inform the final inclusion or exclusion of a research paper in the review. Disagreements arising 
from the results of EW and KBM will be addressed through discussions with ABBM.  
Data synthesis and integration 
The convergent segregated approach will be employed in data synthesis and integration [13]. 
Quantitative data and qualitative data will be synthesized separately. The evidence that will be 
generated from the separate synthesis of quantitative and qualitative data will be integrated [13]. 
27 
 
Quantitative and Qualitative data synthesis  
The synthesis of quantitative data will be done through a meta-analysis or narrative synthesis 
depending on the feasibility of the pool of data to be analyzed statistically [13].  
The findings from the pool of qualitative data will undergo meta-synthesis through findings 
assembly and categorization based on shared meanings [22]. These categorized findings will 
undergo further analysis in an attempt to generate a wealth of evidence that will be easy to 
comprehend and will also be a true reflection of the awareness of women on prostate cancer 
concerning the underpinned review objectives [13].   
In the event of the inability to perform a textual pooling, a narrative will be generated [22]. The 
synthesis by narrative will be performed according to the following approach; the findings 
obtained from the selected studies will undergo preliminary synthesis, the compiled data will be 
explored for linkages and the synthesizing process will be assessed for robustness [23].     
Integration of quantitative evidence and qualitative evidence 
The evidence from the individual analysis of quantitative and qualitative data will undergo 
configuration [13]. The inability of evidence configuration will result in the narrative presentation 
of evidence [13]. 
Discussion 
This protocol is a blueprint to be followed for conducting a mixed-methods systematic review to 
map up evidence on the awareness of women on prostate cancer. To cover a wide range of primary 
literature, the protocol will employ the mixed-methods approach according to the JBI guidelines. 
By publishing the study protocol, we strengthen the clarity of the search strategy and reduce the 
risk of bias, particularly selective outcome reporting. 
The wealth of evidence obtained from this systematic review will inform and support the 
involvement of women as health promoters and educators in the early detection and prevention of 
prostate cancer. The evidence will also be useful in improving the quality of life and survival rate 




The potential limitations of this research  
The study is confronted with selection bias resulting from the following; 
1. The restriction of the literature search to the range of January 1999 to December 2019. 
2. The consideration of studies published only in the English language for inclusion. 
3. Limiting the literature search to 5 databases. 
4. The exclusion of studies conducted in women who have received prior education on 
prostate cancer, exclusion of healthcare professionals, healthcare students, and 
college/university students. 
5. The exclusion of studies that involved lesbian, gay, bisexual, transsexual/transgender, and 
queer/questioning (LGBTQ) participants. 
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The mixed-methods systematic review protocol developed in chapter 2 A was employed to gather 
evidence, from January 1999 to December 2019, about prostate cancer awareness among women. 



























CHAPTER 2 B 
SUBMITTED MANUSCRIPT 
Prostate Cancer Awareness among Women: A Mixed-methods Systematic Review. 
ABSTRACT 
Objectives: This systematic review seeks to gather evidence from studies that investigated 
women’s knowledge about; (1) the signs and symptoms, (2) causes and risk factors, and (3) the 
screening modalities of prostate cancer. 
Methods: The convergent segregated approach to the conduct of mixed-methods systematic 
reviews was employed. Five databases namely; MEDLINE (EBSCOhost), CINAHL 
(EBSCOhost), PsycINFO (EBSCOhost), Web of Science, and EMBASE (Ovid) were searched 
from January 1999 to December 2019 for studies conducted with a focus on the knowledge of 
women on the signs and symptoms; the causes and risk factors; and the screening modalities of 
prostate cancer. 
Results: Of 2201 titles and abstracts screened, 22 full-text papers were retrieved and reviewed, 
and 7 were included: 3 quantitative, 1 qualitative, and 3 mixed-methods studies. Both quantitative 
and qualitative findings indicate that women have moderate knowledge of the signs and symptoms; 
and the causes and risk factors of prostate cancer. However, women recorded poor knowledge 
about prostate cancer screening modalities or tools. 
Conclusion: Moderate knowledge of women on the signs and symptoms, and the causes and risk 
factors of prostate cancer were associated with education. These findings provide vital information 
for the prevention and control of prostate cancer and encourage policy-makers to incorporate 
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health promotion and awareness campaigns in health policies to improve knowledge and 
awareness about prostate cancer globally. 
Trial registration number: Open Science Framework (OSF) registration DOI: 
https://doi.org/10.17605/OSF.IO/BR456  
Keywords: Awareness, Signs and symptoms, Causes and risk factors, Screening recommendations, 
Prostate cancer, Women.  
Abbreviations: CDC: Centers for Disease Control and Prevention; DRE: digital rectal 
examination; GLOBOCAN: Global Cancer Incidence, Mortality and Prevalence; JBI: Joanna 
Briggs Institute; LGBTQ: Lesbian, Gay, Bisexual, Transsexual/transgender, and 
Queer/questioning; OSF: Open Science Framework; LMIC: low and middle-income countries; 












Prostate cancer (PCa) is the most common non-skin cancer occurring in men and is accountable 
for 3.8% of all mortality caused by cancer in men.1,2 According to the GLOBOCAN, 2018 
database, it is estimated that it is the fifth primary cause of cancer death in men globally. It further 
reported that the highest mortality rate is found in the Caribbean and Southern African men 
worldwide.1,3 A recent study by Yeboah-Asiamah et al. (2017) reported that PCa was the second 
most common cancer in areas such as Australia, the United States, and New Zealand.4 Though 
fewer than 30% of all incidence of PCa are from developing countries, these countries have 
previously been estimated to have the highest mortality from PCa due to late diagnosis.5,6 Although 
sub-Saharan Africa (SSA) has a low rate of the disease, the incidence is projected to increase if 
screening is encouraged.7 Hence, PCa remains a vital public health concern in both developed and 
developing countries. 
The Centers for Disease Control and Prevention (CDC) in North America, organized a workshop 
with the motive to explore strategies to control and prevent the disease based on the increasing 
incidence and mortality rate of PCa.8 To address mortality rates related to the disease, participants 
recommended strategies to improve PCa awareness.8 Also, as documented by many studies, PCa 
incidence is a direct reflection of the rate at which high-risk groups screen for the disease.4,9 In 
Europe, early screening was attributed to a 20% reduction in PCa mortality rate.10 Although there 
is evidence suggesting a reduction in PCa mortality due to early screening, a United States (US) 
study did not highlight a reduction in mortality.11 The prostate-specific antigen (PSA) test and the 
digital rectal examination (DRE) are useful screening tools, although initial controversies were 
surrounding the use of these tools.12 Because of overlap in PSA levels in men with prostatitis, 
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benign prostatic hyperplasia, and PCa, it was assumed that PCa cannot be screened using the PSA 
test.13 Catalona et al. (1991) demonstrated that PSA could be utilized as a screening tool for PCa 
and it has widely been adopted.14 DRE is the only procedure whereby physicians can examine part 
of the prostate gland.15 The findings are only based on the physician impression, hence poor inter-
rater reliability and also a limitation to the palpable region of the prostate gland.15 However, DRE 
sometimes detects PCa in men with PSA, 4.0 ng/mL.16 Regardless of the controversial nature of 
screening and the potential for early screening to reduce mortality, studies support the need to 
encourage screening.4,15  
Women have essential characteristics that make them better managers of family health as 
compared to men. Therefore, it is not surprising that there is evidence positioning women as 
individuals who make adequate observations about the health of their partners.9,17 In promoting 
the early detection of PCa, women have been documented to observe the slightest symptoms 
presented by their partners and push them to seek medical attention.9,18 In a study conducted by 
Blanchard et al. (2005) it was recommended that efforts must be made to actively involve women 
in improving the timely detection of PCa through the closure of knowledge-gaps.19   
Also, men admit seeking out their wives’ opinions as sources of health information.20 In the context 
of the early detection of PCa, women can play various roles such as information seekers, advocates, 
health advisors, and support persons.21 Therefore, there is the need to gather current evidence about 
women’s knowledge of PCa as the findings will be vital in equipping women to contribute towards 
the early detection of the disease. 
In light of the availability of limited evidence addressing the awareness of women on prostate 
cancer, this review will seek to combine quantitative and qualitative data to increase the validity 
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of findings through data triangulation as recommended by Caruth (2013) and supported by 
Lizarondo (2017) and colleagues.22,23 Thus, this review seeks to map out current evidence 
regarding women’s awareness of PCa under the scopes of: 1) signs and symptoms, 2) risk factors 
and causes, and 3) screening guidelines.  
Methodology 
The Joanna Briggs Institute (JBI) reviewer’s manual for the conduct of mixed-methods critical 
appraisal and synthesis formed the backbone of the study.23 With guidance from the JBI manual, 
a protocol was developed to guide the review process according to the convergent segregated 
approach.23 The respective DOIs of the review protocol and review, registered with the Open 
Science Framework (OSF), are https://doi.org/10.17605/OSF.IO/EYHF2 and 
https://doi.org/10.17605/OSF.IO/BR456.  
Inclusion criteria 
We considered studies that were published in English and peer-reviewed journals between January 
1999 and December 2019. Included studies were selected from primary research of any 
methodology; and explored awareness on signs and symptoms, causes and risk factors, and 
screening of prostate cancer. Studies that were conducted among women regardless of the 
geographical location were included. Studies that were mainly conducted in men were excluded 
in addition to studies not published in the English language. 
Information sources and search strategy 
An initial explorative search in PubMed founded search terms in preparation for a comprehensive 
electronic search. The selected search terms were combined with Boolean operators for a 
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comprehensive electronic search in MEDLINE (EBSCOhost), CINAHL (EBSCOhost), PsycINFO 
(EBSCOhost), Web of Science, and EMBASE (Ovid) as “(prostate cancer ) AND (awareness OR 
knowledge) AND (signs OR symptoms) AND (risk factors OR causes) AND (screening) AND 
(women)”. The search strategy (Appendix 1), so developed, was utilized by the first (EW) and 
second (KBM) reviewers to independently conduct a literature search as outlined in the review 
protocol.24 
Selection of studies 
The first and second reviewers, being guided by the developed review protocol, independently 
screened and compared the titles and abstracts of the literature search outcomes to a developed 
standard (Appendix 2). Studies that successfully passed the initial stage of screening were 
subjected to the independent full-text reading by EW and KBM before consideration for data 
extraction. Lastly, hand-searching and snowballing on references of selected articles were done to 
find eligible studies in the grey area. There were no disagreements between EW and KBM. Hence, 
the third reviewer (ABBM) assessed the studies before data extraction was conducted by the lead 
author according to the JBI data extraction tools outlined in the review protocol.24 The 
characteristics of studies that successfully went through the data extraction, the key findings that 
were extracted, and a summary of the study selection process are detailed respectively (Table 1, 
Table 2, and Figure 1). 
Quality assessment 
As described in the review protocol,9,18 the methodological quality assessment tool (Appendix 3) 
was adopted and modified for this review.25 The tool appraised the studies' quality based on the 
studies sample representativeness, response rate, reliability, and validity of the data collection tool. 
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The tool was modified to suit the results from the included studies. A score was calculated, and 
the quality of the studies was classified as weak (0% to 33.9%), moderate (34% to 66.9%), or 
strong (67% to 100%). Eligible records were subjected to independent quality assessment by EW 
and KBM. Methodological quality outcomes were not grounds for exclusion. 
Synthesis and integration of findings 
The review findings were subjected to the convergent segregated approach to synthesis and 
integration according to the developed review protocol.24 A narrative synthesis was separately 
performed for qualitative and quantitative findings. The results were finally integrated.  
Results 
Conducting the review, according to the developed protocol, yielded 2200 studies results. A 
detailed citation screening led to an additional study, which increased the total studies to 2201. 
Regarding the summary of the study selection process (Figure 1), 1672 studies were obtained after 
529 duplicates were removed from the pool of data. Post- titles and abstracts review excluded 1650 
studies leaving 22 studies. The 22 studies were further reduced to 7 after a full-text reading resulted 
in the exclusion of 15 studies. 
Characteristics of included studies 
The data extracted from the seven (7) studies are detailed (Table 1). The publication years ranged 
from 2003 to 2018 with 5 studies having been conducted in the United States. One of the studies 
was a multicenter study that involved multinationals.26 The study with the highest female 
participants (4040 women) was conducted in Spain.27 Webb et al. (2006) recruited the lowest 
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sample size, 14 women.28 A total of 5634 women were involved in the 7 studies. Two studies were 
solely conducted in women, three included other diseases, and two did not disclose study duration.  
Quality of included studies 
According to the scoring scheme of the quality assessment tool (Appendix 3), two studies27,28 were 
evaluated as moderate-quality whilst five studies were evaluated as strong quality. None of the 
studies were excluded based on methodological quality assessment outcomes. There was no 
disagreement between EW and KBM. 
Review findings 
Study findings, presented in table 2, were heterogeneous. Quantitative studies indicate that women 
knew about the existence of PCa. In exploring qualitative evidence, women exhibited knowledge 
of PCa. Therefore, both arms of the review are supportive of each other. 
Women had moderate knowledge about the signs and symptoms of PCa drawing from quantitative 
findings. The asymptomatic nature of early staged PCa; and women moderately knew urinary 
symptoms such as urinary frequency, difficulty in urinating, and dysuria. Qualitative studies 
indicate that women were aware of signs and symptoms such as urinary frequency, difficulty in 
urinating, glandular enlargement of the prostate, and erectile dysfunction. Hence, quantitative and 
qualitative findings revealed that women moderately knew the urinary symptoms of PCa. 
Quantitative studies indicate an average score of women on knowledge of risk factors of PCa. Risk 
factors women knew were increasing age, presence of a first-degree relative, being genetically 
linked to Africa, and excessive truncal obesity. Qualitative evidence recognized all risk factors 
documented by the quantitative findings except truncal obesity. Also, identified risk factors 
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included poor diet, inadequate exercise, stressful lifestyle, poor screening habits, cigarette 
smoking, and poor access to quality healthcare. Women wrongly reported sexual orientation and 
frequent sexual activity as risk factors. Therefore, qualitative findings confirm the quantitative 
claim that women have shared knowledge about the risk factors of PCa. 
Quantitative studies indicate that women had poor knowledge about PCa screening. Although it 
was reported that women knew about PSA and DRE, knowledge scores were significantly low. 
Also, women poorly recognized urine as a screening sample, PSA as an exclusive diagnostic tool, 
and failed to identify more than one screening tool. Qualitative studies respectively reported PSA 
and blood as a screening tool and sample. Colonoscopy was wrongly reported as a PCa screening 
tool. Conclusively, both arms of the review reported women knew about PSA and had poor 
knowledge about PCa screening. 
Discussion 
The heterogeneity of the study findings warranted the synthesis as a narrative.23,29 The convergent 
segregated approach was employed according to the recommendation of the JBI reviewer’s 
manual.23 
Generally, from the quantitative evidence, women knew about prostate cancer.19,26,30.31 The 
knowledge of women was found to have increased with educational and financial status;19 and 
disease familiarity.19,31 The awareness of women about the existence of PCa increased when the 
disease was mentioned compared to an initial request for women to list cancers.26 Qualitative 
evidence showed that women were aware of PCa.18,30 They appreciated and specifically requested 
for PCa education partly because they could not tell the location of the prostate gland.18 Thus, 
quantitative and qualitative evidence indicates that women know about PCa. Women’s awareness 
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could be due to their role in family health management and the possible health-seeking behavior 
of educated and financially strong women. As persons are faced with the experiences of a health 
condition, they will seek to make sense of this illness by acquiring knowledge,32 experiences, and 
beliefs; hence this theory might explain the improved awareness of women who were familiar with 
the disease. 
Most of the quantitative studies indicate that women are aware of the asymptomatic nature of 
early-stage PCa.19,30,31 Symptoms that women had a fair knowledge about included urinary 
frequency, difficulty in urinating, and dysuria.31 Findings from one of the qualitative studies 
indicate that women fairly recognized urinary frequency, difficulty in urinating, glandular 
enlargement of the prostate, and erectile dysfunction as signs and symptoms of PCa.18 Being 
familiar with the disease may explain the awareness of women of the urinary symptoms associated 
with PCa.   
According to Okoro and colleagues’ quantitative study (2018), although knowledge of PCa was 
not adequate, women knew associated risk factors such as being a first-degree relative, being a 
man of African descent, and excessive truncal obesity.30 Blanchard et al. (2005) also documented 
women’s recognition of increasing age as a PCa risk factor.19 One of the qualitative studies 
indicates women knew increasing age could increase a man’s chance for PCa development.18,28 
Other causes and risk factors women identified included poor diet, inadequate exercise, stressful 
lifestyle, family history of the disease, being of African descent, poor screening habits, cigarette 
smoking, and poor access to quality healthcare.18 Erroneously, one study reported that women 
perceived sexual orientation and frequent sexual activity as risk factors.18 Both quantitative and 
qualitative findings documented women knew increasing age, family history, and African descent 
as PCa risk factors. 
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Quantitatively, women’s responses to queries about PCa screening were poor.26,31 Some women 
were unable to recognize at least a PCa screening tool whilst others mistakenly recognized urine 
as a suitable sample for PCa screening.26 According to Okoro et al. (2018) the majority of women 
exclusively tagged PSA elevation as a basis for PCa diagnosis.30 This, therefore, calls for extensive 
education because benign prostatic hyperplasia, prostatitis, and PCa usually present with elevated 
PSA.13 Evidence from qualitative findings indicated women knew physical examination must 
augment blood analysis.28 Also, women mentioned PSA and colonoscopy as screening tools.18 The 
results from included qualitative studies confirmed that women had poor knowledge about PCa 
screening. The mention of colonoscopy as a screening tool further supports a lack of adequate 
knowledge about PCa screening. 
This critical appraisal and synthesis revealed over the 20 years of study search, only four studies 
out of the seven included studies investigated all the outcomes of interest. Two studies did not 
investigate women’s awareness of the signs and symptoms27,28 and the causes and risk factors27,31 
of PCa. Therefore, although quantitative and qualitative findings were supportive of each other, 
studies investigating the causes and risk factors, as well as the signs and symptoms of PCa, were 
lacking. 
Recommendations for Practice 
From the review findings, it is recommended that PCa control programs should also focus on 
educating women. Clinicians and public health practitioners should include women in prostate 
cancer health promotion. Women should be encouraged to attend PCa clinics with their male 
significant others suffering from the disease and the effect of this strategy in reducing PCa 
mortality rate investigated.  
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Recommendations for Research 
Further studies are recommended to investigate the knowledge of women living in low and middle-
income countries (LMIC) about PCa. Such studies should focus extensively on the knowledge of 
women on PCa screening. Also, it is recommended for research to develop and pilot a PCa 
educational intervention model, applicable to women to reduce the burden of the disease. This tool 
should be culturally-specific for easy acceptance and recognition. Also, current evidence on the 
willingness of women to offer social support to men with PCa should be investigated. 
Study Limitations 
The various restrictions that were imposed on the literature search included a search range from 
January 1999 to December 2019, a search into only 5 databases, and the outright exclusion of non-
English publications. 
Other limitations were the exclusion of studies conducted in women who received education on 
prostate cancer, healthcare professionals, healthcare students, and college/university students, and 
further exclusion of studies that involved (LGBTQ) participants. 
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Figure 1: Summary of the study selection process. 
 
Total number of studies 
discovered from included 
database (n = 2200) 
Total number of out of 
database studies 
discovered (n = 1) 
Total number of studies for 
consideration (n = 2201) 
Total number of studies after 
deduplication (n = 1672) 
Total number of duplicated studies 
removed (n = 529) 
Total number of studies considered for 
title and abstract screening (n = 1672) 
Studies excluded post title and 
abstract screening (n = 1650) 
Studies considered for full-text 
assessment (n = 22) 
Studies excluded post full-text 
assessment (n = 15) 
 
Studies without outcome of interest (n 
= 10) 
Abstract articles (n= 5) 
Studies included in data extraction and 



































































United States Caucasians/Whites, 
African-
Americans/Blacks, 
Hispanics/Whites, and  
Hispanics/Blacks    
Women None. 
Brown et al., 
2006 
United States African-Americans and 
Afro-Caribbeans 










Spain  Spanish  Men and women Colorectal 
cancer, breast 
cancer, and 
cervical cancer.  
Okoro et al., 
2018 
United States  Black/African-
Americans 
Men and women None. 
Owens et 
al., 2015 






Kingdom, and the 
United States 
Western Europeans and  
Americans 





Webb et al., 
2006 
United States Blacks (non-Hispanics) 
and Hispanics/Latinos 







Table 1 (continued) 
AUTHOR 
AND YEAR 





Quantitative study Missing 324 




Five (5) days 221 
Carrasco-





Two (2) months 4040 (50.9% of 7938) 
Okoro et al., 
2018 
Cross-sectional  mixed 
methods study 
Three (3) months 297 
Owens et al., 
2015 
Mixed methods study About 2 months 38 
Schulman et 
al., 2003 
Quantitative study (Telephone 
interview) 
Nineteen (19) days 700 
Webb et al., 
2006 





















Table 2: Summarized study findings 
STUDY TITLE FINDINGS CONCLUSION LIMITATIONS 
Knowledge, 
Attitudes and 





(Blanchard et al., 
2005). 
1. The mean score for 
women's knowledge 
about prostate cancer and 
screening guidelines was 
determined to be 6.99 ± 
3.54 out of 15 points.                                                                                     
2. Educational level and 
income were discovered 
to have increased the 
mean score for women's 
knowledge.                                                        
3. Women who disclosed 
their familiarity with 
cancer of the prostate and 
available screening 
recommendations 
recorded higher scores in 
knowledge assessment.                                                   
4. Only 54.3% of women 
knew about the 
asymptomatic 
presentation of prostate 
cancer in early stages.                                                     
5. About 37% of women 
failed to recognize age as 
a risk factor for prostate 
cancer.                                                                          
6. 83.9% of women were 
of the known that men, 
symptomatic or not, 
should screen for prostate 
cancer.                                                  
7. 54% of married and 
42% of single women 
recognized the early 
detection of prostate 
cancer as the key 







could equip women 
to contribute to the 
early detection of 
prostate cancer by 
encouraging men to 
screen routinely for 
the disease. 
1. Women might not 
have documented true 
responses to 
questionnaire items 
since a self-reporting 
technique was 
employed in the 
study.                                         
2. The study was 
limited to only 
women fluent in the 
English language and 
hence, findings could 
not be extended to 
cover all women in 
New Orleans.                       
3. The use of the 
convenience sampling 
method in the study 
exposed the study to 
participants’ selection 
bias and hence, a 
negative impact on 
the generalization of 
study findings.  
53 
 
importance of screening.                    
8. Married (41%) and 
single (32%) women 
agreed that men feared 
prostate cancer screening 
results as well as the 
application of the digital 









in urban settings 
(Brown et al., 
2006). 
1. Generally, the 
knowledge score of 
women on the symptoms 
of prostate cancer was 
appreciable.                                                      
2. Women who knew 
about the existence of 
prostate cancer in their 
families had higher 
knowledge scores.                                           
3. 24% of women 
responded prostate cancer 
is asymptomatic; whilst 
65%, 67%, and 63% 
respectively noted the 
difficulty in passing 
urine, dysuria, and the 
need to frequently pass 
urine as symptoms.                                                         
4. Women found it 
difficult in identifying 
tools applicable to 
prostate cancer screening.                                                            
5. 46%, 61%, and 38% of 
women respectively 
selected prostate-specific 
antigen (PSA), digital 
rectal examination 
(DRE), and x-ray as 




prostate cancer but 





needed to upgrade 
the knowledge of 





1. The study suffered 
various forms of 
selection bias as the 
participants were 
conveniently selected 
from salons that were 
interested in the 
health promotion 
initiatives of the 
Arthur Ashe Institute 
for Urban Health 
(AAIUH).                                                                  
2. The study was 
restricted to women 
who used the services 
of the selected salons 
and hence, the study 
findings could not be 
a true reflection of all 
New York women.                                                                      
3. There was an 
observation of a high 
number of correctly 
answered questions.  
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screening tests in 
Spain (Carrasco-
Garrido et al., 
2014). 
1. 51.56% of Spanish 
women knew PSA as a 
prostate cancer screening 
tool.                                                                              
2. Education and social 
status significantly 
increased women's 
awareness of PSA as a 
prostate cancer screening 
tool. 
The use of prostate-
specific antigen 
(PSA) for prostate 
cancer screening is






1. The validity and 
reliability of the 
survey instrument 
were not done in the 
study population.                                                 
2. Respondents might 
have given socially 
acceptable responses 
when their awareness 
about PSA was tested.                                                                        
3. Women who knew 
about PSA as a 
prostate cancer 
screening tool might 












1. On a 25 knowledge-
score scale, women's 
mean score was 11.4 ± 
5.1.                                                                                          
2. No idea accounted for 
29.1% of women's 
responses to prostate 
cancer knowledge.                                                          
3. The focused group 
discussion involving 
women revealed an 
overall poor prostate 
cancer knowledge.                                      
4. The PSA as a prostate 
cancer confirmatory tool 
and the recommended 
age for universal prostate 
cancer screening received 
the worst correct 
response rates.                                                 
5. Only 17.5% of women 
The knowledge and 
awareness of 
women about 
prostate cancer are 








1. The study included 
only African-
American women and 
hence, findings cannot 
be extended to cover 
all women in 
America.                                                    
2. The study suffered 
selection bias as 
participants were 
conveniently sampled.                                         
3. The survey 
instrument did not 
undergo validation 
and reliability 
assessment in the 
study population.                 
4. The study engaged 
relatively young 
participants and hence 
findings could not be 
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knew elevated PSA levels 
did not exclusively 
indicate the existence of 
prostate cancer.                      
6. As low as 13.5% of 
women knew universal 
prostate cancer screening 
is not exclusively a 
recommendation for only 
men above 50 years.                                                                                     
7. The educational status 
of women greatly 
increased knowledge 
scores.                                                                                         
8. 62.3%, 57.2%, and 
38.7% of women 
respectively identified the 
presence of a first-degree 
relative, being a man of 
African descent, and 
excessive truncal obesity 
as risk factors of prostate 
cancer.      
9. Women (54.5%) knew 
the asymptomatic nature 
of prostate cancer.                                                                                         
10. 47.5% of women 
recognized DRE as a tool 
for the early detection of 
prostate cancer.                                                        
11. Women (40.7%) 
indicated the need for 
risk assessment before 
the initiation of prostate 
cancer screening; whilst 
54.2% agreed with the 
recommendation that 
men who are 40 - 45 
years and are at risk for 
the development of the 
an exact 
representation of all 
age groups.                                                                
5. The study 
participants, being 
young, might have 














American men and 





& Hébert, 2015). 
1. Women had limited 
knowledge about prostate 
cancer.                    
2. The only signs and 
symptoms of prostate 
cancer women were 
conversant with included 
urinary frequency, 
difficulty in urinating, an 
enlarged prostate gland, 
and erectile dysfunction.                          
3. Women acknowledged 
knowing very little about 
prostate cancer and called 
for education.                                                               
4. Most women did not 
know the location of the 
prostate gland in addition 
to the available screening 
tools. Nevertheless, the 
PSA was mentioned.                                                                            
5. Some women 
perceived colonoscopy as 
a prostate cancer 
screening tool.                                                                              
6. Risk factors that 
attracted much attention 
from women included; 
poor diet (high red meat 
and fatty food 
consumption) and 
inadequate physical 
activity.                                                          
7. Other risk factors that 
did not attract much 
The knowledge of 







improved. There is 





women on prostate 
cancer. 
1. The relatively small 
sample size of the 
interest population 
hindered results 
generalizability.                              
2. The study was 
limited to African-
Americans and hence, 
findings could not be 
generalized to cover 
other races/ethnic 
diversities in the study 
site.                        
3. The participants 
were conveniently 







increased age (where age 
greater or equal to 45 
years was tagged the 
highest risk), stressful 
lifestyle, family history 
of the disease, being of 
African decency, poor 
screening habit, cigarette 
smoking, and poor access 
to quality healthcare.                                           
8. Women erroneously 
perceived a man's 
sexuality and regularity 
of sexual intercourse as 
risk factors.  
Awareness of 
prostate cancer 
among the general 






1. 100 women each from 
7 countries were involved 
in the study.                                                    
2. 28% of female 
respondents 
spontaneously included 
prostate cancer in their 
list of available cancers 
whilst 69%, who didn't 
initially list prostate 
cancer, agreed to the 
existence of the disease 
when asked a closed-
ended question.                                           
3. Women in the United 
Kingdom (40%), United 
States (20%), France 
(23%), Germany (24%), 
Italy (21%), Spain (26%), 
and Sweden (39%) were 
spontaneously aware of 
prostate cancer. When 
prompted, additional 
respective 58%, 76%, 
The recognition of 
the basic prostate 
cancer screening 
tools by women 
was very low. The 
general awareness 
of prostate cancer 
was lacking in 
women. To 
promote the early 
detection of 
prostate cancer in 




targeting women is 
needed. 
1. The study failed to 
indicate the 
percentage of women 
who were able to 
identify the signs and 
symptoms, and risk 
factors of prostate 
cancer.             
2. The number of 
participants from the 
various countries was 
relatively small to 
promote the 
generalizability of 
results.                                            
3. Respondents might 
have given socially 
approved responses 
since data collection 
was through a 
telephone interview.                                                    
4. The validity and 




70%, 75%, 76%, 69% 
and 61% of women 
recognized the existence 
of prostate cancer.                                                                            
4. Women in Spain 
(36%), the United States 
(35%), Italy (23%), 
Sweden (22%), the 
United Kingdom (17%), 
France (17%), and 
Germany (9%) 
recognized PSA as a 
prostate cancer screening 
tool.                                                                                             
5. 20% of women in the 
United States, 14% in 
France, 8% in Spain, 6% 
in the United Kingdom, 
6% in Germany, 5% in 
Italy, and 2% in Sweden 
recognized DRE as a 
prostate cancer screening 
tool.                                                                                            
6. Mistakenly, 37% of 
women in Spain, 22% in 
Italy, 17% in France, 
13% in the United 
Kingdom, 10% in 
Germany, 11% in 
Sweden, and 5% in the 
United States recognized 
the use of urine as a 
prostate cancer screening 
sample.                                                                                            
7. The inability of women 
to recognize at least a 
prostate cancer screening 
tool followed the trend: 
Germany (71%), Sweden 
(60%), the United 




Kingdom (56%), the 
United States (53%), 
France (52%),  Italy 
(44%) and Spain (41%).  












1. Women disclosed that 
prostate cancer may 
occur in men who are or 
greater than 65 years old. 
However, women were 
not sure if a diet has 
caused a reduction in the 
age at which men 
develop prostate cancer.                                                                            
2. During the FDG, some 
women agreed that 
prostate cancer screening 
starts when men celebrate 
their 40th birthday.                 
3. The use of blood as a 
screening sample for 
prostate cancer detection 
was mentioned by 
women. However, 
women reported the need 
for a physical body 
examination in addition 







women on prostate 
cancer screening is 
of equal 
importance as male 
prostate cancer 
education. 
1. Results have low 
generalizability due to 
the utilization of the 
convenience sampling 
strategy.                               
2. Validity and 
reliability studies of 
the FGD questions 
were not done in the
study population.                         
3. The target number 
of study subjects 
needed for the FDG 
was not met. Hence, 













The results of chapter 2 B revealed that women had moderate knowledge about the signs and 
symptoms and the risk factors of prostate cancer. The review further indicated that women had 
poor knowledge about the screening modalities of prostate cancer. The results directed the 
researcher to develop an Akan questionnaire for studying prostate cancer awareness in Ghanaian 
women.  A validation and reliability assessment of the Akan questionnaire was also performed. It 
was then prepared as a manuscript and presented in chapter 3. The manuscript was prepared 

























An Akan Translation, Validation and Reliability of a Questionnaire for assessing 
Awareness of Ghanaian women about Prostate Cancer. 
ABSTRACT 
Aims: The study aimed to: (1) adopt, modify and develop a questionnaire suitable for data 
collection on prostate cancer in the female population, (2) translate the questionnaire into the Akan 
language, and (3) conduct a validity and reliability analysis on the Akan questionnaire. 
Methods: An English version questionnaire was developed and adequately translated into an Akan 
version according to the forward and backward translation protocols. The Akan questionnaire went 
through translator-approval and certification. Validity and reliability analysis were performed on 
the questionnaire. Statistical analysis for face validity involved the determination of average scores 
while content validity involved the determination of the content validity index. Regarding 
reliability analysis, Cronbach’s alpha was calculated for the test and retest periods of study. 
Results: A forty-five (45) numbered Akan questionnaire was successfully developed and certified. 
The average scores for all parameters employed in the face validation were greater than 4. The 
content validity index was within the range of 0.90 - 0.99 while the Cronbach’s alpha for both test 
periods was within the range of 0.7808 - 0.9209. 
Conclusion: The Akan questionnaire had acceptable validity and reliability outcome. Therefore, 
the questionnaire was considered appropriate for assessing knowledge, awareness, and perception 
of Ghanaian women about prostate cancer. 
Keywords: Akan questionnaire, Translation, Validity analysis, Reliability analysis, Knowledge, 
Awareness, Perception, Prostate cancer, Women.  
Abbreviations: BREC: Biomedical Research Ethics Committee; CHRPE: Committee on Human 
Research, Publications and Ethics; CVI: Content Validity Index; KATH: Komfo Anokye Teaching 
Hospital; PCa: Prostate cancer; KNUST: Kwame Nkrumah University of Science and Technology; 




The promotion of family health is attributed to women, including the wellbeing of their 
acquaintances [1,2]. A study conducted in North America stressed the influence women have on 
their relatives regarding their health-seeking demeanor [3]. Other roles women have been shown 
to play towards health promotion include the provision of health-related advice, their acting as 
advocates for various medical conditions including cancers, and their unique role in providing 
support for the sick [4]. According to Taylor and colleagues (2016), husbands confirmed soliciting 
health information from their significant others [5]. Therefore, there is evidence to support the 
crucial role women could play towards the early detection of prostate cancer (PCa).  
Globally, several studies have identified the knowledge, awareness, and perception of women 
about PCa as moderate [3,6,7]. In Ghana, a literature search on the awareness of women of PCa 
did not yield any studies. This result indicates the need to conduct such research. However, there 
are about 50 indigenous Ghanaian languages [8], with Akan been the most spoken language [9]. 
Providing a valid and reliable Akan version of a modified tool for assessing the awareness of 
women of prostate cancer is vital. Such a tool should be subjective, useful in a female setting, 
reliable, and valid. Therefore, this study was conducted with the following objectives; (1) to adopt 
and adapt a questionnaire suitable for data collection on awareness of PCa in Ghanaian women, 
(2) to translate the questionnaire into the Akan language, and (3) to conduct a validity and 
reliability analysis on the Akan questionnaire.  
METHODOLOGY 

































Figure 1: A flowchart illustrating the Translation, Validity and Reliability Analysis Methodology 
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Development of the English Version Questionnaire 
The English version questionnaire was adopted from a study by Otoo (2010) when she undertook 
a study on prostate cancer awareness in Ghanaian military men [10]. The questionnaire was 
modified with inputs from a study conducted by Blanchard et al. (2005) [3]. The developed 
questionnaire was submitted to the Committee on Human Research, Publications and Ethics 
(CHRPE) of the Kwame Nkrumah University of Science and Technology (KNUST), and the 
Biomedical Research Ethics Committee (BREC) of the University of KwaZulu-Natal (UKZN). 
The CHRPE accepted and approved the questionnaire whilst a recommendation from BREC to 
reduce questionnaire length informed the final English version of the questionnaire. The English 
version questionnaire was resubmitted to BREC for approval. 
Forward Translation and Approval 
The approved English version was subjected to a forward translation into Akan. The forward 
translation entails converting a document from an original language into a second language of 
interest [11,12]. Three translators with academic degrees in the Akan language and fluent in the 
English language translated the English version into the Akan version. The translators considered 
the Akan version for approval. English words, such as the prostate that did not have literal 
meanings in the Akan language were adequately given descriptions as previously done in a study 
by Nejjari et al. (2014) [13]. 
Backward Translation and Approval 
The Akan version of the questionnaire was back-translated into the English language by three 
translators with academic degrees in the English language and fluent in the Akan language. This 
method was by similar studies involving the translation of questionnaires into different native 
languages [11,12]. The translators considered the back-translated English version for approval. 
Assessment, Approval, and Certification 
The backward translation version, which is the second English version, was assessed by the six (6) 
independent translators. The assessment involved a thorough comparison of the second English 
version to the ethically-approved English version for conceptual agreement [11]. The forward 
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translation version, which is the Akan version, was further assessed by the six (6) independent 
translators and considered for translator-approval before submission to the Department of 
Language and Communication Sciences of KNUST for certification.  
Questionnaire Validation 
The variables of the construct of the Akan questionnaire was assessed for face and content validity 
[12,14]. Content validity is the extent to which a set of variables comprehensively covers the 
different components of the questionnaire [15]. On the contrary, face validity is whether the 
questionnaire's variables are appropriate, sensible, and suitable to the population intended for use 
[16]. 
Face validation 
Face validation must preferably be performed by non-expert participants on the construct being 
studied [14]. It is the simplest validation method and the weakest type of validity [14]. In a study 
by Sowtali et al. (2016) ten (10) non-experts (stroke patients) were employed in the face validation 
[14]. To ensure the same number of individuals were employed in the translation, face validation, 
and content validation processes, six (6) market women fluent in the Akan language were 
randomly selected to evaluate the Akan questionnaire for face validity. The market women scored, 
on a scale of 6 (very week, week, moderately week, good, very good, excellent) [17], the 45 
variables of the Akan questionnaire according to language appropriateness, clarity, and cultural 
acceptance [11,14]. The average points scored by the market women were computed into excel 
[17].  
Content validation 
The content validation focused on the relevance of the questionnaire to the study and the 
questionnaire’s ability to measure the study construct [12,14]. Six (6) experts adequately assessed 
the content validity of the questionnaire items [12]. Typically, 5 to 7 experts are used to evaluate 
whether the variables of interest are well represented in the questionnaire [18]. Therefore, two 
pharmacists with a Doctor of Pharmacy and Master’s degree in clinical pharmacy, two oncology 
nurses, and two clinical oncologists at the Komfo Anokye Teaching Hospital (KATH), Ghana 
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scored the questionnaire. Items of the questionnaire were scored on a scale of three (3) (poor, 
moderate, good) according to the relevance of the items to the study [17]. The Content Validity 
Index (CVI) was determined and computed [14].   
Reliability Assessment 
The Akan questionnaire reliability was assessed to verify the tool’s ability to measure the domains 
of the study according to the test-retest method at an interval of seven (7) days [17,19]. Retesting 
was relevant in reducing the order effect [17]. It also measures the test's internal validity and 
ensures that the results obtained are reliable and can replicate themselves repeatedly in the same 
population and situation. The duration of the test-retest was 14 days. 
Population 
A portion of the female traders on the ground floor of the Kumasi Central Market, also known as 
the Kejetia Market, located in the Ashanti region of Ghana, was employed in the reliability study. 
Only women who consented to the study and volunteered to be available for the retest period were 
recruited. Women below 18 years and female mobile traders were excluded. 
Sample size and sampling technique 
According to the administrative manager, the market holds about 25,000 female traders. In 
determining sample size for a conventional study at a confidence level (c) of 95%; a precision level 
(e, sampling error) of +/-5%, and a degree of variability (p) of 50%; an estimated sample size of 
400 is recommended according to published tables by Israel (1992) [20]. For the reliability study, 
100 women (25% of the recommended sample size) were recruited. To obtain an intra-class 
correlation coefficient (ICC) of not less than 0.75±0.1 at a 95% confidence interval, a sample size 
of 51 is appropriate [19]. Other studies recruited a lesser sample size [14] and relatively higher 
sample sizes [17,19]. 
To reduce bias and ensure an equal chance of participation, the women were simply and randomly 
sampled [21]. The ground floor of the market was divided into four (4) sections and each section 





STATA software was employed for statistical evaluation. The internal reliability of the Akan 
questionnaire was measured using Cronbach’s alpha [17,19]. To measure the constructs of face 
validity, descriptive statistics were used. 
RESULTS 
Translation Outcome 
A sixty-one (61) item questionnaire was adopted and adapted (Appendix A). The questionnaire 
was modified to forty-five (45) (Appendix B) in response to BREC (Appendix C). The forward 
and backward translations were approved by the respective translators. The translator-approved 
English version questionnaire was found to be conceptually equivalent to the original English 
version questionnaire. The Akan version (Appendix D) was approved by all six (6) independent 
translators. The translator-approved Akan version received certification (Appendix E) from the 
Department of Language and Communication Sciences, KNUST. 
Validity Analysis Outcome 
The face validity scores have been computed in table 1. The questionnaire, taking all the various 
sections into account, had an average validity score range of 4.17 - 6.00 (4.73 ± 0.90) on language 










Table 1: Face validity results 
Sections Language 
Appropriateness 




Mean ±SD Average 
score 
(range) 




1 4.17 - 4.83 4.44 ± 0.93 4.33 - 5.33 4.69 ± 0.78 4.67 - 5.33 5.17 ± 0.93 
2 4.33 - 5.00 4.60 ± 0.93 4.50 - 5.17 4.81 ± 0.78 4.67 - 5.67 4.98 ± 0.90 
3 4.33 - 5.17 4.72 ± 0.87 4.50 - 5.33 5.06 ± 0.68 4.33 - 5.67 5.15 ± 0.78 
4 4.33 - 4.67 4.53 ± 0.85 4.67 - 5.00 4.80 ± 0.75 4.33 - 5.33 4.77 ± 0.84 
5 4.50 - 5.33 4.67 ± 0.77 4.67 - 5.50 5.17 ± 0.78 4.17 - 5.33 4.88 ± 0.91 
6A 4.50 - 6.00 5.00 ± 0.93 5.16 - 6.00 5.47 ± 0.56 5.33 - 5.83 5.67 ± 0.54 
6B 4.67 - 5.50 5.17 ± 0.86 5.17 - 5.67 5.40 ± 0.55 5.33 - 5.50 5.33 ± 0.75 
Score (all 
sections) 
4.17 - 6.00 4.73 ± 0.90 4.33 - 6.00 5.04 ± 0.76 4.17- 5.83 5.11 ± 0.86 
 
The Content Validity Index (CVI) has been presented (Table 2). The various sections of the 
questionnaire had a lower limit CVI greater than 0.75 except for section 6B, beliefs about prostate 
cancer, which had a CVI range of 0.73 - 1.00 (0.91 ± 0.44). A CVI range of 0.90 - 0.99 (0.96 ± 













Reliability Analysis Outcome 
The socio-demographics of the participants are presented in table 3, and graphically in figures 2 - 
7.  The age of participants ranged from 18 - 72 years (41.96 ± 15.288 for the test, and 42.17 ± 
15.154). The leading socio-demographical classes were; married reflecting marital status, primary 
reflecting highest educational level, Christianity to religion, Akan under the major ethnic group 
section, and non-membership of market associations.  
 
 
Table 3: Demographical features of study subjects (n= 100) 
Variable Test Retest 
Age (Mean ± SD) 41.96 ± 15.288 42.17 ± 15.154 
Age (Minimum) 18 18 
Age (Maximum) 72 72 
   
Sections Relevance of Variables to Study 
Content Validity Index (CVI) 
range 
Mean ±SD 
1 0.89 - 1.00 0.96 ± 0.31 
2 0.92 - 0.96 0.95 ± 0.35 
3 0.93 - 1.00 0.97 ± 0.29 
4 0.93 - 1.00 0.99 ± 0.18 
5 0.95 - 1.00 0.99 ± 0.15 
6A 0.80 - 1.00 0.93 ± 0.40 
6B 0.73 - 1.00 0.91 ± 0.44 
CVI (all sections) 0.90 - 0.99 0.96 ± 0.32 
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Age (Ranges)   
15-19 2 2 
20-24 18 17 
25-29 9 9 
30-34 8 8 
35-39 4 4 
40-44 11 12 
45-49 17 17 
50-54 9 9 
55-59 5 5 
60+ 19 19 
   
Marital Status   
Married 47 49 
Never married 25 25 
Cohabiting 8 7 
Widowed 15 14 
Divorced/Separated 5 5 
Highest Educational level   
Primary 46 50 
Secondary 35 32 
Tertiary 11 10 
No education 8 8 
Religious Affiliation   
Christianity 92 92 
Islamic 7 7 
Other 1 1 
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Ethnic Background   
Akan  90 90 
Mole-Dagbane 2 2 
Other  8 8 
   
Market Association   
Hair Sellers  1 1 
Kejetia Market Union 1 1 
Make-Up Sellers 2 2 
Petty Traders 1 1 
None 95 95 
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Figure 3: A frequency graph of the marital status of study participants for the test and retest phases. 
 
 









Married Never married Cohabiting Widowed Divorced/Separated









Primary Secondary Tertiary No education










































Figure 7: A frequency graph of the market associations of study participants for the test and retest 
phases. 
 
Cronbach’s alpha values obtained in determining the internal reliability of the Akan questionnaire 
are reported in table 4. Alpha values for the various sections of the questionnaire, taking into 
account the test and retest periods, were above 0.5 except section 6. For the two sections of the 
questionnaire that evaluated the perception of women on prostate cancer, the sub-section on 
women’s attitudes towards prostate cancer had a Cronbach’s alpha of 0.4637 at baseline and 
0.2314 for the retest. Cronbach’s alpha of the sub-section that evaluated beliefs about prostate 
cancer was 0.2211 at baseline and increased to 0.3427 during the retesting period. The overall 
Cronbach’s alpha for all the variables, grouped and ungrouped, for the test and retest was within 
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Table 4: Cronbach’s reliability test  
Sections Test  Retest 
2. Awareness about prostate cancer 0.6161 0.5486 
3. Knowledge on signs and symptoms of prostate cancer 0.9364 0.8883 
4. Knowledge on the causes of prostate cancer 0.7070 0.7005 
5. Knowledge on the risk factors of prostate 0.7749 0.6634 
6A. Attitude towards prostate cancer 0.4637 0.2314 
6B. Beliefs about prostate cancer 0.2211 0.3427 
Cronbach’s alpha for all variables (grouped into sections) 0.8101 0.7808 
Cronbach’s alpha for all variables (ungrouped) 0.9209 0.8892 
 
DISCUSSION 
The Akan questionnaire was developed to assess the knowledge, awareness, and perception of 
women towards prostate cancer. The questionnaire is hoped to aid in studies aimed at equipping 
Ghanaian women to contribute to the early detection of prostate cancer. The translation procedure 
was successful and received adequate certification. The face and content validation were 
performed on the Akan version to assess the feasibility of questionnaires to adequately measure 
the study construct of interest and determine the relevance of variables to the study [14]. The 
reliability analysis was performed to determine the Akan questionnaire’s ability to adequately 
measure the domains of the study [12]. 
According to Nahad et al. (2014), face validity scores greater than 4, on a scale of 6, reflect an 
excellent questionnaire validity [17]. On a scale of 5, scores of 3 and 4, respectively represent 
adequate and very suitable absolute face validity [22]. From the results (Table 1), all sections of 
the questionnaire had an average validity score greater than 4 for language appropriateness, clarity, 
and cultural acceptance. Therefore, the questionnaire had good face validity. The results further 
affirm the ability of the Akan questionnaire to measure the study construct of interest adequately. 
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From the submission of Yaghmaei (2003), a content validity index (CVI) greater than 0.75 
describes a good content validity outcome [23]. Some studies have successfully evaluated the 
content validity of questionnaires according to the recommendation of Yaghmaei (2003) [14,17]. 
In general, the questionnaire exhibited a good content validity outcome as a CVI range of 0.90 - 
0.99 (0.96 ± 0.32) was calculated. Although section 6B of the questionnaire had a lower limit CVI 
of 0.73, the mean was found to be 0.91 and could be generally considered a good content validity 
outcome. 
According to Sowtali et al. (2016), Cronbach’s alpha values between 0.5 to 0.7 are acceptable, 
while values of 0.7 and higher reflect apparent questionnaire items homogeneity [14]. The 
Cronbach’s alpha values of sections 6A (0.4637 for test and 0.2314 for retest) and 6B (0.2211 for 
test and 0.3427 for retest) were below the lower acceptable limit. However, the overall Cronbach’s 
alpha for all the variables, grouped and ungrouped, exhibited an acceptable internal reliability and 
questionnaire items homogeneity as outcomes for both test and retest were within the range of 
0.7808 - 0.9209. Therefore, the Akan questionnaire has acceptable internal reliability and 
homogeneity. 
CONCLUSION 
The Akan version of the questionnaire was successfully developed and certified. The validity and 
reliability analysis of the questionnaire was acceptable. It is recommended that the questionnaire 
be used to study the knowledge, awareness, and perception of Ghanaian women about prostate 
cancer. Given this recommendation, the Akan questionnaire can be used to study prostate cancer 
awareness in Ghanaian women adequately.   
STUDY LIMITATIONS 
1. The questionnaire validity and reliability analysis was restricted to the Kejetia Market and 
did not include Ghanaian women from other places in the country. 
2. The reliability analysis was restricted to the evaluation of only internal reliability. 
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This chapter concludes the study by highlighting the key findings. Also, the significance of the 
research project, strengths, limitations, recommendations for further studies, and a summary of the 
study is adequately presented in this chapter. 
Women have been tagged the managers of family health with evidence from how they wonderfully 
navigate the immunization schedule of their newborns in addition to the many prenatal and 
postnatal schedules the global health community demands of them. With the increase in the late 
detection of prostate cancer and the need to exploit cost-effective means of increasing the early 
detection of the disease, this research was to develop a tool to be used specifically in Ghana to 
study the knowledge, awareness, and perception of women about prostate cancer.  
The objectives below were set to achieve the study aim: 
1. To conduct a mixed-methods systematic review on the awareness of women about prostate 
cancer. 
2. To translate, validate, and conduct a reliability assessment of a questionnaire for studying 
the knowledge, awareness, and perception of prostate cancer in Ghanaian market women. 
4.2 CONCLUSIONS DRAWN FROM STUDY FINDINGS BASED ON STUDY 
OBJECTIVES 
The study contributed to scientific knowledge as follows; 
1. The development of a mixed-methods systematic review protocol suitable to gather 
evidence on women’s awareness about prostate cancer. 
2. The systematic review revealed that women had moderate knowledge about the signs and 
symptoms, and risk factors of prostate cancer. 
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3. The review further highlighted the poor knowledge women had about prostate cancer 
screening modalities. 
4. A prostate cancer tool, specifically for Ghanaian women, was developed and validated. 
5. The 45-item Akan questionnaire was reliable and could be used to study the awareness of 
Ghanaian women about prostate cancer.  
4.3 SIGNIFICANCE OF THE STUDY 
The development of a tool to be used specifically in Ghana to study the knowledge, awareness, 
and perception of women about prostate cancer is relevant in ensuring the timely detection of the 
disease. The tool, in the Akan language, would be useful in further studies to determine the 
awareness of Ghanaian women about prostate cancer in addition to developing an educational 
intervention model. Although all Ghanaian women are not Akans, the Akan dialect is widely 
spoken and well understood by the majority of Ghanaians. With this tool, the Ghanaian woman 
stands the chance to be given education on prostate cancer and further equipped to contribute to 
early detection.   
4.4 STRENGTHS  
1. The review employed the mixed methods approach to the critical appraisal and synthesis 
of evidence. 
2. None of the search records were excluded from the review based on methodological 
quality. 
3. The search records included all global studies. 
4. Study participants were randomly selected. 
5. The Akan questionnaire was developed according to the forward and backward 
translation. 
6. The validation of the questionnaire involved the face and content validation techniques. 
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7. The test-retest approach was employed in the reliability assessment of the Akan 
questionnaire. 
4.5 LIMITATIONS 
1. The literature search for the review was limited to 5 databases and to the search range of 
January 1999 to December 2019. 
2. Studies that included women who received education on prostate cancer were excluded 
from the review. 
3. Literature search records that included healthcare professionals, healthcare students, 
college/university students, and Lesbian, Gay, Bisexual, Transsexual/transgender, and 
Queer/questioning (LGBTQ) participants were excluded from the review. 
4. The questionnaire validation and reliability assessment were restricted to only women in 
the Kejetia market. 
5. The reliability analysis was restricted to the evaluation of only internal reliability. 
4.6 RECOMMENDATIONS 
1. Prostate cancer programs, aimed at early detection, must involve the active engagement 
of women as screening promotors. 
2. The knowledge of women, living in low and middle-income countries (LMIC), about 
prostate cancer, must be studied. 
3. The current burden of prostate cancer on women, whose significant others are living with 
prostate cancer, must be investigated.  
4. An educational intervention model must be developed to strategically position women to 





4.7. SUMMARY OF STUDY 
In brief, this study has revealed the insufficient studies conducted globally on the awareness of 
women on prostate cancer. The study has further developed an Akan questionnaire that aims to 
study the knowledge, awareness, and perception of Ghanaian women in the bid to strategically 
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APPENDIX 1: Proposed search strategy using Medline via EBSCOhost  
1.  Awareness* OR Aware* OR Awarenesses*  
2. Knowledge* OR Know* OR Knowledges* OR Knowledgeable* OR Known* OR 
Knowns* OR Know-how* OR Knowledge-base* 
3. Signs and symptoms* OR Early signs and symptoms* OR Signs* OR Symptoms* OR Early 
manifestations* OR Manifestations* OR Symptomatology* OR Symptomatologies* 
4. Risk factors* OR Risk factor* OR Causes* OR Cause* OR Predisposing factors* OR 
Predisposing factor* OR Triggering factors* OR Triggering factor* OR Trigger* OR 
Triggers* Underlying cause* OR Underlying causes* 
5. Screening recommendations* OR Screening Recommendation* OR Screening Guideline* 
OR Screening Guidelines* OR Screening Guideline Recommendations* OR Screening 
Suggestions* OR Screening Procedures* OR Screening Methods* OR Diagnostic 
Guidelines* OR Diagnostic Methods* OR Diagnostic Tests* OR Diagnostic Tools* OR 
Diagnostic Recommendations* OR Diagnostic Procedures* OR Diagnostic Processes* OR 
Investigations* OR Laboratory Investigations* OR Clinical Investigations* OR 
Examinations* OR Laboratory Examinations* OR Clinical Examinations* OR Assessment 
Methods* OR Testing Tools* OR Testing Methods* OR Testing Guidelines*   





7. Women* OR Woman* OR Ladies* OR Lady* OR Female* OR Females* OR Young 
women* OR Young woman* OR Young Lady* OR Young ladies* OR Wife* OR Wives* 
OR Mother* OR Mothers* OR Feminine* OR Maiden* OR Maidens OR Bride* OR 
Brides* OR Dame* OR Dames*   
8. #1 OR #2 
9. #3 OR #4 OR #5 
10. #8 AND #9 
11. #10 AND #6 
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APPENDIX 2: Joanna Briggs Institute (JBI) Data Extraction Tools       
A. JBI MASTARI DATA EXTRACTION TOOL FOR QUANTITATIVE RESEARCH 
Reviewer: ………………………………….. Date: ………………………………………….. 
Author: …………………………………….  Year: ………………………………………….. 
Journal: ……………………………………  Record number: ………………………………. 
Study Method 
RCT                                           Quasi-RCT                             Longitudinal 






Intervention 1…………….. Intervention 2 ………………. Intervention 3 ……………… 
 
Interventions  
Intervention 1 ……………………………………………………………………………………… 
Intervention 2 …………………………………………..………………………………………….. 





















   
   
 
Continuous Data 
Outcome Control group mean & SD 
(number) 
Control group mean & SD 
(number) 
   
   






























      B. JBI QARI DATA EXTRACTION TOOL FOR QUALITATIVE RESEARCH 
Reviewer: ………………………………….. Date: ………………………………………….. 
Author: …………………………………….  Year: ………………………………………….. 
Journal: ……………………………………  Record number: ………………………………. 
Study Description 
Methodology: …………………………………………. 
Phenomena of Interest: ……………………………. 
Setting: …………………………………. 
Geographical location: ……………………………….. 
Cultural background: …………………………………. 
Participants: ………………………………………… 
Data Analysis: …………………………………… 
Authors’ Conclusions: ………………………………………. 
Comments: …………………………………………….. 
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APPENDIX 3: Quality Assessment Tool      





ASSESSMENT CRITERIA (GQAC) 
SPECIFIC QAC PERCENTAGE 
SCORE 
A B C D E F G H 
          
          
          
          
          
 
KEY 
SN= Serial Number 
GQAC= General Quality Assessment Criteria 
QAC= Quality Assessment Criteria 
A= Was the study population adequately represented by the selected study sample size?; B= Did 
the study document a response rate?; C= Did the data extraction instrument undergo a reliability 
assessment?, D= Did the data extraction instrument undergo a validity assessment?; E= Does this 
study contribute to the primary source of data?; F= Was the knowledge of women on the signs and 
symptoms of prostate cancer assessed?; G= Was the knowledge of women on the causes and risk 
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factors of prostate cancer determined? H= Was the knowledge of women on the availability of 
screening guides for prostate cancer detection ascertained? 
SCORING SCHEME 
Yes (Y)= 1; No (N) or Unclear (U) or Not Reported (NR)= 0  
PERCENTAGE SCORE= 100((Selected Study Total Scores) ÷ (Sum of Assessment Criteria 
Scores)) 





























CHAPTER 2 B 
APPENDIX 1: Proposed search strategy using Medline via EBSCOhost  
1. Awareness* OR Aware* OR Awarenesses*  
2. Knowledge* OR Know* OR Knowledges* OR Knowledgeable* OR Known* OR 
Knowns* OR Know-how* OR Knowledge-base* 
3. Signs and symptoms* OR Early signs and symptoms* OR Signs* OR Symptoms* OR Early 
manifestations* OR Manifestations* OR Symptomatology* OR Symptomatologies* 
4. Risk factors* OR Risk factor* OR Causes* OR Cause* OR Predisposing factors* OR 
Predisposing factor* OR Triggering factors* OR Triggering factor* OR Trigger* OR 
Triggers* Underlying cause* OR Underlying causes* 
5. Screening recommendations* OR Screening Recommendation* OR Screening Guideline* 
OR Screening Guidelines* OR Screening Guideline Recommendations* OR Screening 
Suggestions* OR Screening Procedures* OR Screening Methods* OR Diagnostic 
Guidelines* OR Diagnostic Methods* OR Diagnostic Tests* OR Diagnostic Tools* OR 
Diagnostic Recommendations* OR Diagnostic Procedures* OR Diagnostic Processes* OR 
Investigations* OR Laboratory Investigations* OR Clinical Investigations* OR 
Examinations* OR Laboratory Examinations* OR Clinical Examinations* OR Assessment 
Methods* OR Testing Tools* OR Testing Methods* OR Testing Guidelines*   





7. Women* OR Woman* OR Ladies* OR Lady* OR Female* OR Females* OR Young 
women* OR Young woman* OR Young Lady* OR Young ladies* OR Wife* OR Wives* 
OR Mother* OR Mothers* OR Feminine* OR Maiden* OR Maidens OR Bride* OR 
Brides* OR Dame* OR Dames*   
8. #1 OR #2 
9. #3 OR #4 OR #5 
10. #8 AND #9 
11. #10 AND #6 

















APPENDIX 2: Eligibility criteria 
INCLUSION CRITERIA 
 Studies conducted in women aged 18 years and above. 
 Studies conducted in women of all racial backgrounds. 
 Studies published from January 1999 to December 2019. 
 Studies conducted in women of all geographical locations. 
 Studies of all research designs. 
 All studies on the knowledge of women on the signs and symptoms of prostate cancer. 
 All studies on the knowledge of women on the causes and risk factors of prostate cancer. 
 All studies on the knowledge of women on the screening recommendations of prostate 
cancer. 
 Studies that were published in the English language. 
 Studies with abstract and full text available. 
EXCLUSION CRITERIA 
 Studies that were published before January 1999 or after December 2019. 
 Studies that were not published in the English language. 
 Studies that include women below the age of 18 years. 
 Studies in which the age of included women cannot be established. 
 Studies that did not indicate the number of included women. 
 Studies that exclusively included men without any women component (18 years and 
above). 
 Studies conducted amongst women who were previously given education on prostate 
cancer. 
 Studies involving lesbian, gay, bisexual, transsexual/transgender, and queer/questioning 
(LGBTQ) participants. 
 Studies that included healthcare professionals. 
 Studies that included healthcare and college/university students. 
 Studies that do not include the outcome of interest. 
 Book chapters. 
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 Reviews and overviews. 
 Abstracts and conference papers. 
 Dissertations and thesis. 
 Commentaries and letters to editors.  






















APPENDIX 3: Assessment of methodological quality of included studies  
 







SPECIFIC QAC PERCENTAGE 
SCORE 
A B C D E F G H 
1.(Blanchard 
et al., 2005) 
1 1 1 1 1 1 1 1 100 
2.(Brown et 
al., 2006) 
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KEY 
SN = Serial Number 
GQAC = General Quality Assessment Criteria 
QAC = Quality Assessment Criteria 
A = Was the study population adequately represented by the selected study sample size?; B = Did 
the study document a response rate?; C = Did the data extraction instrument undergo a reliability 
assessment?, D = Did the data extraction instrument undergo a validity assessment?; E = Does this 
study contribute to the primary source of data?; F = Was the knowledge of women on the signs 
and symptoms of prostate cancer assessed?; G = Was the knowledge of women on the causes and 
risk factors of prostate cancer determined? H = Was the knowledge of women on the availability 






Yes (Y) = 1; No (N) or Unclear (U) or Not Reported (NR) = 0  
PERCENTAGE SCORE = 100((Selected Study Total Scores) ÷ (Sum of Assessment Criteria 
Scores)) 
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